Delivery Order SPE2DB22D1106-SPE2DB24FEZZ6
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,785.90, is for the delivery of SUMATRIPTAN 20 MG NASAL SPRAYS. It is a firm fixed-price delivery order contract with a completion date of January 24, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor for this award,...
- This federal contract award, valued at $2,582.52, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,567,201,682 units of SUMATRIPTAN 5 MG NASAL SPRAYS, with a completion date of February 7, 2025. The contract is a Delivery Order under a Firm Fixed Price pricing type, with no set-aside designation indicated. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award, valued at $2,092.97, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of 4565426547 SUMATRIPTAN 20 MG NASAL SPRAYS. The contract, which is a Firm Fixed Price Delivery Order, has an ultimate completion date of August 13, 2024. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is providing these essential medical commodities to support military treatment programs and facilities worldwide. This award is part...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm-fixed price delivery order contract worth $3,410.58 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4562279287 SUMATRIPTAN 20 MG NASAL SPRAYS. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA to supply a comprehensive range of pharmaceutical products and medical supplies to support military...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,575.01, is a Firm Fixed Price Delivery Order for the supply of 4567279665 - SUMATRIPTAN 5 MG NASAL SPRAYS. The contract has an ultimate completion date of February 18, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of SUMATRIPTAN 20 MG NASAL SPRAYS, a medical supply, with a ceiling value of $5,519.49 and a completion date of July 1, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of SUMATRIPTAN 20 MG NASAL SPRAYS. The contract has a firm fixed price of $1,559.58 and a completion date of June 17, 2025. The contract is not set aside and represents an open competition. AmerisourceBergen Drug Corp is the prime contractor, and the contract is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,359.59 firm fixed-price contract is for the delivery of 4565045669 - SUMATRIPTAN 20 MG NASAL SPRAYS. The contract has a period of performance through July 2, 2024 and was awarded on July 1, 2024. No set-aside designation was used for this open competition award. AmerisourceBergen holds a significant Indefinite Delivery...
- This federal contract award, valued at $22,500.13, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4566544600 - SUMATRIPTAN 20 MG NASAL SPRAYS, with a completion date of November 26, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- This federal contract award, valued at $1,345.44, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SUMATRIPTAN 20 MG NASAL SPRAYS, a pharmaceutical product, to support military healthcare programs. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 4, 2025. This contract award is associated with a...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FEZZ6Delivery Order
This federal contract award, with the ID SPE2DB22D1106|SPE2DB24FEZZ6, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,247.27, is for the delivery of 4565048006 - SUMATRIPTAN 5 MG NASAL SPRAYS. It is a firm fixed-price delivery order contract with a completion date of July 2, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor, and the company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.2k | 7/1/24 |